107311-60-4

Upstream product

• 34074-22-1 2,6-dichloro-4-iodophenol 
• 98033-85-3 5-(5-bromopentyl)-3-methylisoxazole 

Downstream Products

• 107311-64-8 5-{5-[4-(3-furanyl)-2,6-dichlorophenoxy]pentyl}-3-methylisoxazole 
• 107311-66-0 5-{5-[2,6-Dimethyl-4-(5-methyl-2-thienyl)phenoxy]pentyl}-3-methylisoxazole 
• 86134-27-2 trimethyl(5-methylthiophen-2-yl)stannane 

Relevant academic research and scientific papers

Antirhinoviral Activity of Heterocyclic Analogs of Win 54954

A variety of heterocyclic analogs of Win 54954 have been synthesized and tested in vitro against human rhinovirus type 14 (HRV-14) in a plaque reduction assay.The more active compounds were tested against 14 additional serotypes, and the concentration whi

A model for compounds active against human rhinovirus-14 based on X-ray crystallography data

A number of (oxazolinylphenyl)isoxazoles have been synthesized and tested against human rhinovirus-14 (HRV-14). Several of the more active compounds have been examined by X-ray crystallography and their orientation in the compound binding site on the caps

Heterocyclic substituted-phenoxyalkylisoxazoles as antiviral useful agents

Compounds of the formula STR1 wherein: Y is an alkylene bridge of 3-9 carbon atoms; Z is N or HC; R is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when Z is N, R is lower-alkyl; R1 and R2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and Het is selected from specified heterocyclic groups, are useful and antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.